UBA2


Summary: Posttranslational modification of proteins by the addition of the small protein SUMO (see SUMO1; MIM 601912), or sumoylation, regulates protein structure and intracellular localization. SAE1 (MIM 613294) and UBA2 form a heterodimer that functions as a SUMO-activating enzyme for the sumoylation of proteins (Okuma et al., 1999 [PubMed 9920803]).[supplied by OMIM, Mar 2010].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in UBA2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IBA GO:0016925 protein sumoylation
BP IDA GO:0016925 protein sumoylation
BP IEA GO:0016925 protein sumoylation
BP IMP GO:0016925 protein sumoylation
BP TAS GO:0016925 protein sumoylation
BP IEA GO:0043085 positive regulation of catalytic activity
Showing 1 to 6 of 25 rows rows per page

Gene expression in normal tissue: UBA2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in UBA2


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human)
reactome R-HSA-2990846 SUMOylation
reactome R-HSA-2990846 SUMOylation
reactome R-HSA-3065676 SUMO is conjugated to E1 (UBA2:SAE1)
reactome R-HSA-3065676 SUMO is conjugated to E1 (UBA2:SAE1)
reactome R-HSA-3065678 SUMO is transferred from E1 to E2 (UBE2I, UBC9)
Showing 1 to 6 of 14 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD748 PHA-665752 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in UBA2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​